Immunohistochemistry and real-Time-PCR, performed on 85 cases of various histopathological subtypes and grades of malignancy found significantly increased expression of Zeb-1 associated to aggressive WHO grade II or III meningiomas. The gene discussed is ZEB1; the disease is meningioma.